Bloomberg Law: SSRI Sexual Dysfunction Label Petition Was Unanswered, Suit Says

The article “SSRI Sexual Dysfunction Label Petition Was Unanswered, Suit Says” by Shweta Watwe has reported on the FDA lawsuit that took place after 6 years of ignorance. Despite posting the petition in 2018 for public comment, the FDA still hasn’t granted or denied it.

Previous
Previous

Reuters: FDA sued by scientist urging sexual side effects warning for widely used depression drugs

Next
Next

The Highwire: SSRIS’ Devastating Side Effects